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Edited by Takashi GojoboriAbstract Membrane-type 5 matrix metalloproteinase (MT5-
MMP) expression is ubiquitous in brain development while
restricted to regions of neuroplasticity in adult. In the multipo-
tent NT2 model of neurogenesis and diﬀerentiation, MT5-
MMP is diﬀerentially expressed with signiﬁcantly higher mRNA
levels in the diﬀerentiated neuronal hNT cells. MT5-MMP
cDNA cloned from NT2 cells unexpectedly revealed a novel
sequence (MT5-MMPvar) characterized by a 162 bp deletion.
Both transcripts were identiﬁed in NT2, hNT and adult human
hippocampus. In vitro, MT5-MMPvar translated into a
55 kDa protein. It was also detected in NT2, hNT and adult
human hippocampus. These results suggest more than one human
MT5-MMP transcript may exist in the central nervous system.
 2007 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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The matrix metalloproteinase (MMP) family of zinc-depen-
dent endopeptidases is comprised of 23 members, several of
which are known to be present in the physiological and path-
ological central nervous system (CNS) [1,2]. In addition to
their established role in extracellular matrix (ECM) degrada-
tion, the MMP family has a wide range of inﬂuences on bio-
logic processes including the generation of bioactive proteins
[3–5]. The most recently identiﬁed subfamily of the MMP fam-
ily is the membrane-type MMPs or MT-MMPs reviewed in [6].
MT5-MMP (MMP-24), the ﬁfth cloned MT-MMP, is
expressed in few tissues including testes, liver, lung and kidney;
however, it is predominately found in the nervous system [7–9].
MT5-MMP expression is ubiquitously expressed during neural
development; while in the adult CNS, it is restricted to speciﬁc
regions, some of which are known to be neurogenic, such as
the hippocampus [7]. Previous work further indicates that neu-Abbreviations: CNS, central nervous system; MMP, matrix metallo-
proteinase; ECM, extracellular matrix; RA, all-trans retinoic acid
*Corresponding author. Address: Harold F. Young Neurosurgical
Center, Virginia Commonwealth University Medical Center, P.O. Box
980631, Richmond VA, United States. Fax: +1 804 827 1487.
E-mail address: hﬁllmore@mcvh-vcu.edu (H.L. Fillmore).
0014-5793/$32.00  2007 Published by Elsevier B.V. on behalf of the Feder
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neurite outgrowth [10].
While existing studies have investigated the presence and
function of MT5-MMP in murine and rodent models, little
data is available on MT5-MMP expression in the human
CNS and neurogenic regions. To begin investigations on the
role of MT5-MMP in human neurogenesis and neural diﬀeren-
tiation, we initiated studies using a well-characterized neuro-
genic in vitro model, the NT2 cell line. Stimulation of NT2
cells with all-trans retinoic acid (RA) leads to the diﬀerentia-
tion of NT2 cells into a 99% purely post-mitotic neuronal pop-
ulation (hNT cells) [11].
In this report, we show that MT5-MMP mRNA is signiﬁ-
cantly increased in diﬀerentiated hNT cells. Analysis of
MT5-MMP cDNA cloned from NT2 cells resulted in the iden-
tiﬁcation of a novel transcript (herein referred to as MT5-
MMPvar) diﬀering from that of the previously reported
MT5-MMP human gene [12]. While 92% homologous to the
reported sequence this transcript is characterized by a 162 bp
deletion within the signal and propeptide domains. Both the
MT5-MMP and MT5-MMPvar transcripts were identiﬁed in
NT2 and hNT cells and in adult human brain tissue. In vitro
transcription/translation studies demonstrated the translation
of an approximately 55 kDa protein from MT5-MMPvar.
Western blot analysis using a deletion spanning antibody
revealed the presence of the corresponding MT5-MMPvar
protein in NT2 and hNT cells and in adult human hippocam-
pus. These results suggest that more than one human MT5-
MMP transcript may exist in the CNS.2. Materials and methods
2.1. NT2 cell culture and human tissue acquisition
Undiﬀerentiated NT2/D1 cells were obtained from ATCC (#CRL-
1973) and maintained in high-glucose DMEM supplemented with 10%
FCS/1% penicillin/streptomycin. Cells were diﬀerentiated according to
an established protocol [11]. Cells were treated with 10 lmol RA for
four weeks. Cells tapped oﬀ the ﬂasks were replated onto matrigel in
the presence ofmitotic inhibitors (cytosine arabinoside [1 lM], ﬂuorode-
oxyuridine [10 lM] and uridine [10 lM]) for 1 week. Cytosine arabino-
side was discontinued and cultures were maintained for an additional 4
weeks. Cells were then replated onto poly-L-lysine coated six well plates
and constituted a 99% pure neuronal culture (hNT). Human adult brain
tissue was obtained from temporal lobe resections in accordance with an
approved IRB protocol from our institution. Tissue was acutely
dissected at the time of harvest into samples corresponding to parahip-
pocampal gyrus or hippocampal formation. Samples from hippocampal
sections were subjected to RNA or protein isolation.ation of European Biochemical Societies.
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Total RNA was isolated from NT2 cells, hNT cells and adult human
brain tissue using TRIzol reagent according to the manufacturers
protocol (Invitrogen, CA). RNA was quantitated using spectro-
photometry and treated with RQ1 DNase (Promega, Madison, WI).
A primer set complimentary to the human MT5-MMP coding
sequence (Table 1A) was designed for automated real time PCR
(VCU Nucleic Acid Research Facility). Cyclophilin A served as an
internal control. Results (n = 3) were analyzed by Students t-test.
2.3. Western blot analysis, antibodies and peptide competition assay
Proteins were isolated from tissue samples as previously described
[13] and from adherent cell lines by incubation of RIPA extraction buf-
fer including protease inhibitor cocktail (Calbiochem, San Diego, CA)
on ﬂasks over an ice bath for 5 min followed by cell scraping. Western
blot analysis was conducted as previously described [13]. Brieﬂy, pro-
teins were quantiﬁed and loaded onto Bis-Tris 4–12% density gradient
gels for SDS–PAGE. Proteins were transferred onto nitrocellulose and
incubated with blocking buﬀer (5% bovine milk in Tris buﬀered saline
plus 0.05% Tween 20). Membranes were probed with the following pri-
mary antibodies: anti-synaptophysin (1:400, Sigma); anti-cyclophilin A
(1:2000, Upstate Biotech); or anti-MT5-MMPvar-produced for our
laboratory and designed to be antigenic only to the 5 0 region of
MT5-MMPvar (1:2000, Primm Biotech). For peptide competition,
anti-MT5-MMPvar antibody (1:2000) was pre-incubated with or with-
out a peptide used to generate MT5-MMPvar antibody (1:200) in
blocking buﬀer at 4 C for 1 h prior to primary antibody incubation.
Following incubation with secondary antibody, immunopositive pro-Table 1
Primer design, location and expected sizes for all PCR experiments
Primer set Primer set application Sequence
A Real time PCR 50tgagccatggacgctagg
50tgcacagccaccaggaag
B Full cDNA 50acacatgccgaggagccg
50gcacccattcctggactg
C 5 0 End 50acacatgccgaggagccg
50gttgggtttggtgcctgg
aRef. [12].
Fig. 1. Expression of MT5-MMP mRNA in NT2 and hNT cells. (A) Phase
image of diﬀerentiated hNT neurons. (C) Veriﬁcation of diﬀerentiation by sy
was used as an internal control. (D) MT5-MMP mRNA levels in NT2 and hN
‘‘Real Time PCR’’. Results expressed as the ratio of MT5-MMP expressionteins were detected by autoradiography using ECL reagents (Amer-
sham Pharmacia Biotech, Piscataway NJ) and quantitated with
densitometry where indicated.
2.4. Cloning of a novel MT5-MMP transcript
Total RNA was isolated from NT2 cells (TRIzol reagent) and used
(1 lg) as a template for reverse transcription (RT). RT product was
PCR ampliﬁed using primers speciﬁc for human MT5-MMP cDNA
(Table 1B) and Advantage GCII DNA polymerase system (Clontech,
Mountain View, CA) with the following cycling conditions: 1 min at
92 C followed by 1 min at 92 C, 1 min at 70 C, 3 min at 72 C for
35 cycles, and ﬁnal extension for 10 min at 72 C. PCR product was
cloned into pTARGET eukaryotic expression vector (Promega,
Madison, Wisconsin) and sequenced (VCU Nucleic Acid Research
Facility and University of Iowa Sequencing Facility). Sequence analy-
sis and alignment was performed online using available software and
databases (Chromas, NCBI, Clustal). The resultant sequence was
submitted to the NCBI database (GenBank Accession No.
DQ300264).
2.5. RT- PCR of the 5 0 end of MT5-MMP
Total RNA was obtained as described above and reverse transcrip-
tion (RT) performed (Invitrogen, Superscript II). RT product was
ampliﬁed (Clontech, Advantage GCII DNA Polymerase) using prim-
ers speciﬁc for the 5 0 end of the MT5-MMP gene (Table 1C) and the
following cycling conditions: 1 min at 92 C followed by 30 s at
92 C, 30 s at 69 C, 1 min at 72 C for 35 cycles, and ﬁnal extension
for 3 mins at 72 C.Location Expected amplicon size
a30 Spanning intron 4 62
a30
gggcg3 0 Start ATG
terminating codon
1938 (MT5-MMP)
gccgc3 0a 1779 (MT5-MMPvar)
gggcg3 0 Start ATG
exon 2
1140 (MT5-MMP)
tgt30 978 (MT5-MMPvar)
contrast image of NT2 cells prior to diﬀerentiation. (B) Phase contrast
naptophysin protein expression by western blot analysis. Cyclophilin A
T cells. Primer sequences and expected amplicon sizes listed in Table 1,
over cyclophilin A (means ± S.D.), n = 3.
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MT5-MMPvar cDNA (sequence conﬁrmed) was subcloned into
pCRT7/CT (Invitrogen, Carlsbad, CA), containing a 3–5 kDa
C-terminal tag fusion protein (Fig. 4A). DNA constructs were trans-
formed into BL21Dea3pLysS bacteria and treated with 1 lM IPTG
for 0–6 h to induce protein expression. Proteins were isolated and pre-
pared for Western blot analysis as described. An antibody against the
V5 epitope found on the C-terminal tag was used for detection (1:2000,
Invitrogen).Fig. 2. Isolation of a novel human MT5-MMP transcript from NT2 cells. (A)
(1% agarose, 0.5 lg/ml Ethidium Bromide). Primer sequences and expected am
of MT5-MMP previously reported and MT5-MMPvar. (C) Amino acid cod
and MT5-MMPvar (bottom panel). Underline, amino acids that are deleted
peptide sequence used for antibody production; Bold underline, Y to H a
Catalytic; H, Hinge; Pex, Hemopexin; S, Stem; T, Transmembrane; C, Cyto3. Results
3.1. MT5-MMP mRNA levels are signiﬁcantly increased in NT2
cells following neuronal diﬀerentiation
The temporal expression pattern of MT5-MMP in rodent
neural development and its expression in adult rodent hippo-
campal neurons have been reported [7,9]. The purpose of our
studies was to begin investigations into the potential role ofVisualization of 1779 bp PCR product obtained from cloning reaction
plicon sizes listed in Table 1, ‘‘full cDNA’’. (B) 5 0 end DNA alignment
e with corresponding schematic for published MT5-MMP (top panel)
from MT5-MMPvar. *, arginine residues found at deletion site; Box,
mino acid change. Protein domains: Si, signal; Pro, Propeptide; Cat,
plasmic tail.
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ings in adult human brain tissue [12]. We ﬁrst examined
MT5-MMP mRNA expression in an in vitro model of adult
neurogenesis and neuronal diﬀerentiation. Using an estab-
lished protocol, multipotent NT2 cells were diﬀerentiated into
neuronal (hNT) cells (Fig. 1A and B) veriﬁed by synapto-
physin immunoblotting (Fig. 1C). Total RNA isolated from
NT2 and hNT cells was subjected to qPCR analysis using
primers speciﬁc for MT5-MMP (Table 1A). mRNA levels were
modest in NT2 cells and signiﬁcantly (P < 0.003) higher in dif-
ferentiated hNT cells (Fig. 1D). Relative values of NT2 and
hNT RNA were normalized to the housekeeping gene, cyclo-
philin A.
3.2. An MT5-MMP transcript cloned from NT2 cells does not
share full sequence homology with the previously reported
sequence
In order to perform functional and expression studies, we
cloned the full length cDNA of MT5-MMP (Fig. 2A) from
NT2 cells using primers speciﬁc for the published human
MT5-MMP gene (Table 1B). Once subcloned into pTARGET
expression vector, the cDNA was sequenced and alignment
analysis was performed. Results from sequence analysisFig. 3. Analysis of the 5 0 region of MT5-MMP cDNA in NT2, hNT
and adult human tissues. RT-PCR results show ampliﬁcation of the
divergent region of the MT5-MMP gene. Primer sequences and
expected amplicon sizes listed in Table 1, ‘‘5 0 End’’. H1–H4,
independent hippocampal surgical samples.
Fig. 4. Translation of MT5-MMPvar cDNA. (A) Schematic representation
epitope. (B) IPTG (1 mM) induction of protein synthesis in bacteria contain
species recognized by an antibody speciﬁc to the V5 epitope. (C) Western b
developed from a peptide speciﬁc to the region which spans the deletion site.
(C, right panel). Cyclophilin A (17 kDa) was used as an internal loading co
MMPvar protein levels in NT2 and hNT samples normalized to cyclophilinshowed that the obtained sequence (MT5-MMPvar) had a
92% sequence homology with that of the published sequence
of human MT5-MMP (Fig. 2B). To determine the location
and nature of the divergent DNA sequence, diﬀerences in
sequence identity were plotted to the corresponding domain
feature of the protein (Fig. 2C). Analysis of MT5-MMPvar
revealed a 162 bp deletion corresponding to an area within
the signal and propeptide domains. A signiﬁcant portion of
the signal peptide (39 amino acids of 52) was deleted as well
as the ﬁrst nine amino acid residues of the propeptide. Addi-
tionally, a single amino acid substitution in the hemopexin-like
domain (Y to H) was observed. Additional database analysis
(PredictProtein program of ExPASy Proteomic tools, SignalP,
Phobius) indicated that while no signiﬁcant functional motif of
the propeptide domain was deleted; (1) the truncated signal
domain was predicted to result in loss of a signal peptide
sequence for direction to the endoplasmic reticulum and (2)
MT5-MMPvar was predicted to associate with the membrane
in the correct orientation, as a type-1 transmembrane protein.
3.3. Two MT5-MMP transcripts can be identiﬁed in NT2 cells,
hNT cells and adult human brain tissue
To analyze further the 5 0 region of the MT5-MMP gene se-
quence, primers were designed to amplify the divergent region
(Table 1C). Expected bands at 978 and 1140 bp represented
MT5-MMPvar and MT5-MMP transcripts, respectively. Re-
sults from RT-PCR analysis demonstrated the presence of
both transcripts in NT2 cells, hNT cells, and in adult human
brain samples (Fig. 3).
3.4. MT5-MMPvar cDNA subcloned into a bacterial expression
system translates into a 55 kDa protein
In order to determine if the cDNA obtained was capable of
translating into a protein, MT5-MMPvar cDNA was sub-of MT5-MMPvar cDNA fused with a C-terminal tag containing a V5
ing MT5-MMPvar/V5 fusion construct resulted in a 55 kDa protein
lot analysis of MT5-MMP in NT2 and hNT cells using an antibody
Antibody speciﬁcity was examined by peptide competition experiments
ntrol. (D) Densitometric analysis was performed to quantitate MT5-
A.
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generate a fusion protein containing a C-terminus tag
(Fig. 4A). Induction of MT5-MMP protein expression in
bacterial cells with IPTG resulted in the translation of a
55 kDa protein, detected using an antibody directed against
the V5 epitope, which adds 3–5 kDa to the protein (Fig. 4B).
To conﬁrm that the variant protein product could be detected
in the cells of origin, an antibody made using a peptide
sequence spanning the deleted region of MT5-MMPvar
transcript (Fig. 2B, shaded box) was utilized. This sequence
(PGPRRAVARADEAEA) was designed and produced
(Primm Biotech) to correspond to the four amino acids
before and the eleven amino acids following the region de-
leted from MT5-MMP. Western blot analysis of NT2 and
hNT protein using this antibody conﬁrmed the presence of
the MT5-MMPvar protein product (Fig. 4C, left panel). Anti-
body speciﬁcity was demonstrated by peptide competition
using the puriﬁed peptide corresponding to the sequence of
the MT5-MMPvar-speciﬁc antibody (Fig. 4C, right panel;
55 kDa bands). Densitometric quantitation revealed an
increase in MT5-MMPvar protein in hNT cells over NT2
levels (Fig. 4D). In all experiments, cyclophilin A was
used as an internal control (Fig. 4C, right panel; 17 kDa
bands).3.5. MT5-MMPvar protein is expressed in adult human
neurogenic regions
We next sought to determine the presence of MT5-MMPvar
protein in neurogenic adult human brain tissue. Western blot
analysis, using the above mentioned deletion spanning anti-
body, revealed the presence of MT5-MMPvar protein in six
independent hippocampi obtained from temporal lobe resec-
tion (Fig. 5A, lanes 1–6, top panel). Peptide competition con-
ﬁrmed antibody speciﬁcity by blocking the endogenous
52 kDa protein species (Fig. 5B). NT2 cell lysate was used
as positive control (Fig. 5A, lane 7). Cyclophilin A was used
as an internal control (Fig. 5).Fig. 5. MT5-MMP protein expression in six independent adult human
surgical tissues. (A) Western blot analysis of proteins isolated from
adult hippocampus using the deletion-spanning MT5-MMPvar anti-
body revealed expression of a 52 kDa protein in 5 of 6 samples. NT2
served as positive control for MT5-MMP expression. (B) Antibody
speciﬁcity was examined by peptide competition. Cyclophilin A
(17 kDa) was used as internal control. Lane assignments: 1–6,
independent surgical samples; 7, NT2 cells.4. Discussion
Due to published reports on the temporal expression of
MT5-MMP in the rodent nervous system [7], and the potential
role of this gene in adult neuroplasticity [10], we sought to
clone this gene for functional as well as expression studies
relating to adult human neurogenesis. Levels of total MT5-
MMP mRNA in diﬀerentiated hNT cells are signiﬁcantly high-
er than that seen in NT2 cells (Fig. 1D). cDNA subsequently
cloned from NT2 cells shares a 92% homology to the reported
MT5-MMP sequence (Fig. 2B). Compared to the reported
MT5-MMP, this novel transcript contains a deletion contain-
ing part of the signal peptide region spanning into the propep-
tide domain. The cDNA amino terminus of both the
previously reported MT5-MMP transcript and this novel
MT5-MMP transcript were identiﬁed in NT2 cells, hNT cells,
and in adult human brain tissue (Fig. 3); however, in this cell
line we were unable to clone the full cDNA of the published
MT5-MMP sequence (Fig. 2A). It should be noted that quan-
titative results in Fig. 1 correspond to total MT5-MMP
mRNA levels as the gene was probed using primers to a region
common to both transcripts. Quantitative analysis of the rela-
tive expression levels of the two transcripts using Taqman real-
time PCR was not performed due to sequence limitations sur-
rounding the deleted region of MT5-MMPvar. This ﬂanking
DNA sequence consists of a small intron-spanning region of
high GC content which was not adequate for the design of
quantitative real-time PCR primers. MT5-MMPvar cDNA
was shown to translate into a full length protein (Fig. 4B).
Quantitation of the detected MT5-MMPvar protein using a
custom MT5-MMPvar antibody shows an increase in MT5-
MMPvar protein in hNT cells (Fig. 4D).
In this report, we used a start codon located upstream from
that which was previously reported for PCR-based cDNA
cloning (12). Kajita et al. have reported similar ﬁndings for
variable MT4-MMP transcripts, in which a second transcript
was found to encode a more highly transcribed sequence and
the only translated protein product [14]. The results presented
here indicate that multiple gene products from the human
MT5-MMP gene may exist and that this newly described tran-
script is expressed in human CNS tissue. Indeed, MT5-MMP-
var protein was found to be expressed in six independent
human hippocampal samples (Fig. 5). Our results demonstrat-
ing the over-expression of MT5-MMPvar in diﬀerentiated hu-
man hNT neurons are in agreement with that of Sekine-
Aizawa et al. [9] in which the authors report the localization
of MT5-MMP to neurons in the rodent CNS. The signiﬁcance
of the 162 bp deletion is not known; however, it is interesting
that this deletion corresponds to a region of trinucleotide re-
peats containing eight Pro, six Leu, and six Ala in the reported
sequence. It has been proposed that this area could give rise to
protein variants due to the instability known to be associated
with such repeats [12]. As database analysis predicts the loss
of functional signal peptide, future studies aim to empirically
determine the functional consequence of this loss. Taken to-
gether these studies support the further characterization of this
gene and its protein products.Acknowledgements:Weare grateful for the excellent technical assistance
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